Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cited by (1,003)

Items 401–500 of 1,003

1. Modulating Protein–Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples
   Rosario González‐Muñiz, M. Ángeles Bonache, M. Jesús Pérez de Vega · 2021 · Molecules
2. Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection
   Huawei Xia, Zeming Zhang, Fuping You · 2021 · Viruses
3. Transferrin receptor is another receptor for SARS-CoV-2 entry
   Xiaopeng Tang, Mengli Yang, Zilei Duan, Zhiyi Liao, Lei Liu, Ruomei Cheng, Mingqian Fang, Wang Gan, Hongqi Liu, Jingwen Xu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
4. Long-term effects of SARS-CoV-2 infection on human brain and memory
   Qiulu Ding, H T Zhao · 2023 · Cell Death Discovery
5. Global impact of proteoglycan science on human diseases
   Christopher Xie, Liliana Schaefer, Renato V. Iozzo · 2023 · iScience
6. Enhanced Tumor Targeting and Penetration of Proteolysis-Targeting Chimeras through iRGD Peptide Conjugation: A Strategy for Precise Protein Degradation in Breast Cancer
   Shipeng He, Yuxin Fang, Minghao Wu, Peifeng Zhang, Fei Gao, Honggang Hu, Chunquan Sheng, Guoqiang Dong · 2023 · Journal of Medicinal Chemistry
7. Deciphering SARS-CoV-2 Virologic and Immunologic Features
   Grégorie Lebeau, Damien Vagner, Étienne Frumence, Franck Ah-Pine, Xavier Guillot, Estelle Nobécourt, Loïc Raffray, Philippe Gasque · 2020 · International Journal of Molecular Sciences
8. Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development
   Vincenzo Lionetti, Sveva Bollini, Raffaele Coppini, Andrea Gerbino, Alessandra Ghigo, Guido Iaccarino, Rosalinda Madonna, Fabio Mangiacapra, Michele Miragoli, Francesco Domenico Moccia et al. · 2021 · Pharmacological Research
9. How dendritic cells sense and respond to viral infections
   Laura Marongiu, Mihai Valache, Fabio Alessandro Facchini, Francesca Granucci · 2021 · Clinical Science
10. A widespread viral entry mechanism: The C-end Rule motif–neuropilin receptor interaction
    Giuseppe Balistreri, Yohei Yamauchi, Tambet Teesalu · 2021 · Proceedings of the National Academy of Sciences
11. Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics
    Hani A. Alhadrami, Ahmed M. Sayed, Hossam M. Hassan, Khayrya A. Youssif, Yasser Gaber, Yassmin Moatasim, Omnia Kutkat, Ahmed Mostafa, Mohamed A. Ali, Mostafa Ezzat Rateb et al. · 2021 · Antibiotics
12. Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2
    Santosh K. Ghosh, Aaron Weinberg · 2021 · Frontiers in Molecular Biosciences
13. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
    Helen Stölting, Laury Baillon, Rebecca Frise, Katie Bonner, Richard J. Hewitt, Philip L. Molyneaux, Mindy L. Gore, William Barclay, Sejal Saglani, Clare M. Lloyd · 2022 · Mucosal Immunology
14. MYH9: A key protein involved in tumor progression and virus-related diseases
    Qing Liu, Chao Cheng, Jiyu Huang, Weiwei Yan, Yinhao Wen, Zhen Liu, Beixian Zhou, Suiqun Guo, Weiyi Fang · 2024 · Biomedicine & Pharmacotherapy
15. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
    Shaimaa Shouman, Nada Elkholy, Alaa E. Hussien, Azza M. El-Derby, Shireen Magdy, Ahmed M. Abou‐Shanab, Ahmed Osama Elmehrath, Ahmad Abdelwaly, Mohamed A. Helal, Nagwa El‐Badri · 2024 · Cell Communication and Signaling
16. Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor
    Sarah O’Keefe, Peristera Roboti, Kwabena B. Duah, Guanghui Zong, Hayden O. Schneider, Wei Q. Shi, Stephen High · 2021 · Journal of Cell Science
17. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells
    Bianca Maria Rotoli, Amelia Barilli, Rossana Visigalli, Francesca Ferrari, Valeria Dall’Asta · 2021 · Biomedicines
18. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
    María Laura Sáiz, Marta L. DeDiego, Darío López-García, Viviana Corte-Iglesias, Aroa Baragaño Raneros, Iván Astola, Víctor Asensi, Carlos López‐Larrea, Beatriz Suárez-Álvarez · 2021 · Clinical Epigenetics
19. COVID‐19 and vertical transmission: assessing the expression of ACE2/TMPRSS2 in the human fetus and placenta to assess the risk of SARS‐CoV‐2 infection
    Max Arran Beesley, Joseph Davidson, Francesco Panariello, Soichi Shibuya, Dominic Scaglioni, Brendan C. Jones, Kasia Maksym, Olumide Kayode Ogunbiyi, Neil James Sebire, Davide Cacchiarelli et al. · 2021 · BJOG An International Journal of Obstetrics & Gynaecology
20. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Fengyi Liang, De Yun Wang · 2021 · Viruses
21. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
    Yash A. Gupta, Oleksandr V. Savytskyi, Matt Coban, Amoghavarsha Venugopal, Vasili Pleqi, Caleb A. Weber, Rohit A. Chitale, Ravi V. Durvasula, Christopher E. Hopkins, Prakasha Kempaiah et al. · 2022 · Molecular Aspects of Medicine
22. How SARS-CoV-2 (COVID-19) spreads within infected hosts — what we know so far
    Sumana Sanyal · 2020 · Emerging Topics in Life Sciences
23. Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking
    José Luis Vique‐Sánchez · 2021 · Bioorganic & Medicinal Chemistry
24. Spike protein of SARS‐CoV‐2 activates macrophages and contributes to induction of acute lung inflammation in male mice
    Xiaoling Cao, Yan Tian, Vi Nguyen, Yuping Zhang, Chao Gao, Rong L. Yin, Wayne E. Carver, Daping Fan, Helmut Albrecht, Taixing Cui et al. · 2021 · The FASEB Journal
25. SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems
    Fei Zhang, Wan Li, Jian Feng, Suzane Ramos da Silva, Enguo Ju, Hu Zhang, Yuan Chang, Patrick S. Moore, Haitao Guo, Shou‐Jiang Gao · 2021 · Journal of Medical Virology
26. Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release
    Hazel Stewart, Roberta Palmulli, Kristoffer H. Johansen, Naomi N. McGovern, Ola M. Shehata, George Carnell, Hannah K. Jackson, Jin S. Lee, Jonathan C. Brown, Thomas Burgoyne et al. · 2023 · EMBO Reports
27. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
    Zhen-Lin Yang, Yulu Wang, Yu-jia Jin, Yuan-Fei Zhu, Yan-Ling Wu, Cheng Li, Yu Kong, Wen-Ping Song, Xiaolong Tian, Wuqiang Zhan et al. · 2021 · Signal Transduction and Targeted Therapy
28. Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
    Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, Gordon L. Love, Luis Del Valle · 2023 · Cells
29. SARS-CoV-2, a Threat to Marine Mammals? A Study from Italian Seawaters
    Tania Audino, Carla Grattarola, Cinzia Centelleghe, Simone Peletto, Federica Giorda, Caterina Lucia Florio, Maria Caramelli, Elena Maria Bozzetta, Sandro Mazzariol, Giovanni Di Guardo et al. · 2021 · Animals
30. Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract
    Roberto Berni Canani, Marika Comegna, Lorella Paparo, Gustavo Cernera, Cristina Bruno, Caterina Strisciuglio, Immacolata Zollo, Antonietta Gerarda Gravina, Erasmo Miele, Elena Cantone et al. · 2021 · Frontiers in Pediatrics
31. Impact of mutations in SARS-COV-2 spike on viral infectivity and antigenicity
    Wenyang Zhou, Chang Xu, Pingping Wang, Anastasia A. Anashkina, Qinghua Jiang · 2021 · Briefings in Bioinformatics
32. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
    Michael J. Christie, Aaron Trent Irving, Samuel C. Forster, Benjamin J. Marsland, Philip M. Hansbro, Paul J. Hertzog, Claudia A. Nold‐Petry, Marcel F. Nold · 2021 · Science Immunology
33. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage
    Nikhil Kirtipal, Sanjay Kumar, Sumit Kumar Dubey, Vivek Dhar Dwivedi, K Gireesh Babu, Petr Malý, Shiv Bharadwaj · 2022 · Infection Genetics and Evolution
34. The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour
    A. S. Oliveira, D. Shoemark, Amaurys Avila Ibarra, A. Davidson, I. Berger, C. Schaffitzel, A. Mulholland · 2021 · bioRxiv
35. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
    Marwah Karim, Sirle Saul, Luca Ghita, Malaya Kumar Sahoo, Chengjin Ye, Nishank Bhalla, Chieh‐Wen Lo, Jing Jin, Jun‐Gyu Park, Belén Martínez-Gualda et al. · 2022 · Antiviral Research
36. Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response
    Gustavo Garcia, Yijie Wang, Joseph Ignatius Irudayam, Arjit Vijey Jeyachandran, Sebastian Castillo Cario, Chandani Sen, Shen Li, Yunfeng Li, Ashok Kumar, Karin Nielsen‐Saines et al. · 2022 · PLoS Biology
37. The Weight of Obesity in Immunity from Influenza to COVID-19
    Fernanda Brandi Andrade, Ana Cristina Moura Gualberto, CAMILA PEREIRA DE REZENDE, Nathércia Percegoni, Jacy Gameiro, Eugênio Damaceno Hottz · 2021 · Frontiers in Cellular and Infection Microbiology
38. Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights
    Michelle Elena Schober, Andrew T. Pavia, John F. Bohnsack · 2021 · Pediatric Critical Care Medicine
39. Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
    William R. Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F. Carroll, Bruce A. Keyt, Lila M. Strohl · 2022 · BioDrugs
40. Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
    Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, A‐Ling Song, Xi Zhu, Jia‐Mei Peng, Rui‐Min Liang, Chen‐Hui Yang, Xiaowei Yu, Xun Huang et al. · 2022 · Journal of Medical Virology
41. Should we discount the laboratory origin of COVID-19?
    Rossana Segreto, Yuri Deigin, Kevin McCairn, Alejandro Sousa, Dan Sirotkin, Karl M. Sirotkin, Jonathan J. Couey, Adrian Jones, Daoyu Zhang · 2021 · Environmental Chemistry Letters
42. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
    Alessandro Ottaiano, Stefania Scala, Crescenzo D’Alterio, Anna Maria Trotta, Anna Maria Bello, Giuseppina Rea, Carmine Picone, Mariachiara Santorsola, Antonella Petrillo, Guglielmo Nasti · 2021 · Therapeutic Advances in Medical Oncology
43. Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2
    Arthur Colson, Christophe Louis Depoix, Géraldine Dessilly, Paméla Baldin, Olivier Danhaive, Corinne Hubinont, Pierre Sonveaux, Frédéric Debiève · 2021 · American Journal Of Pathology
44. Determinants of expression of SARS‐CoV‐2 entry‐related genes in upper and lower airways
    Hananeh Aliee, Florian Massip, Cancan Qi, Maria Stella de Biase, Jos van Nijnatten, Elin T.G. Kersten, Nazanin Zounemat Kermani, Basil Khuder, Judith M. Vonk, Roel C.H. Vermeulen et al. · 2021 · Allergy
45. Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations
    Jonathan D. Ravid, Orly Leiva, Vipul Chimanlal Chitalia · 2022 · Cells
46. SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: Clinical implications
    Lynn A. Vitale-Cross, Ildikó Szalayova, Aiden Scoggins, Miklós Palkovits, Éva Mezey · 2022 · EBioMedicine
47. Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
    Hoda Zarkoob, Anna Allué‐Guardia, Yu‐Chi Chen, Andreu Garcia‐Vilanova, Olive Jung, Steven L. Coon, Min Jae Song, Jun‐Gyu Park, Fatai S. Oladunni, Jesse Miller et al. · 2022 · Communications Biology
48. Signal peptide mimicry primes Sec61 for client-selective inhibition
    Shahid Rehan, Dale Tranter, Phillip P. Sharp, Gregory B. Craven, Eric Lowe, Janet L. Anderl, Tony Muchamuel, Vahid Abrishami, Suvi H. Kuivanen, Nicole A. Wenzell et al. · 2023 · Nature Chemical Biology
49. Exosome-Mediated mRNA Delivery For SARS-CoV-2 Vaccination
    Shang-Jui Tsai, Chen-Xu Guo, A. Sedgwick, Saravana Kanagavelu, Justin Nice, Sanjana Shetty, Connie Landaverde, Nadia A. Atai, S. Gould · 2020 · bioRxiv
50. Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora
    Khalid Saad Alharbi, Yogendra Prasad Singh, Waleed Hassan Almalki, Sushama Rawat, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Imran Ahmed Kazmi, Fahad Ahmed Al-Abbasi, Sami Ibrahim Alzarea, Sachin Kumar Singh et al. · 2022 · Chemico-Biological Interactions
51. SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?
    Kathy O. Lui, Zhangjing Ma, Stefanie Dimmeler · 2023 · Cardiovascular Research
52. SARS-CoV-2 immunity in animal models
    Zhaoming Chen, Yaochang Yuan, Qingtao Hu, Ai-Ru Zhu, Fenghua Chen, Shu Li, Xin Guan, Chao Lv, Tian Tang, Yi-Yun He et al. · 2024 · Cellular & Molecular Immunology
53. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate
    Endika Prieto‐Fernández, Leire Egia‐Mendikute, Laura Vila-Vecilla, Alexandre Bosch, Adrián Barreira-Manrique, So Young Lee, Ana García-del Río, Asier Antoñana-Vildosola, Borja Jiménez-Lasheras, Leire Moreno‐Cugnon et al. · 2021 · Emerging Microbes & Infections
54. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses
    Morvarid Siri, Sanaz Dastghaib, Mozhdeh Zamani, Nasim Rahmani-Kukia, Kiarash Roustai Geraylow, Shima Fakher, Fatemeh Keshvarzi, Parvaneh Mehrbod, Mazaher Ahmadi, Pooneh Mokarram et al. · 2021 · International Journal of Molecular Sciences
55. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
    Kruglova, Natalia, Siniavin, Andrei, Gushchin, Vladimir, Mazurov, Dmitriy · 2021 · Viruses
56. Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
    Tomoshige Kino, Irina D. Burd, James H. Segars · 2021 · International Journal of Molecular Sciences
57. Single-cell RNA sequencing of SARS–CoV-2 cell entry factors in the preconceptional human endometrium
    Felipe Vilella, Wanxin Wang, Inmaculada Moreno, Beatriz Rosón, Stephen R. Quake, Carlos Simón · 2021 · Human Reproduction
58. SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells
    Jinliang Wang, Guan Yang, Xinxin Wang, Zhiyuan Wen, Lei Shuai, Jie Denny Luo, Chong Wang, Ziruo Sun, Renqiang Liu, Jinying Ge et al. · 2021 · Cell Discovery
59. Chronic Rhinosinusitis and COVID-19
    Concepció Marı́n, Thomas R. Hummel, Zheng Liu, Joaquim Mullol · 2022 · The Journal of Allergy and Clinical Immunology In Practice
60. SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes
    Titilola D. Kalejaiye, Rohan Bhattacharya, Morgan A. Burt, Tatianna Travieso, Arinze Emmanuel Okafor, Xingrui Mou, Maria Blasi, Samira Musah · 2022 · Frontiers in Cell and Developmental Biology
61. Revealing the mystery of persistent smell loss in long COVID patients
    Jung Woo Park, Xiaoyan Wang, Ren‐He Xu · 2022 · International Journal of Biological Sciences
62. Infectious Causes of Stroke
    Sireesha Murala, Elanagan Nagarajan, Pradeep C. Bollu · 2022 · Journal of Stroke and Cerebrovascular Diseases
63. On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein
    John E. Chittum, Nehru Viji Sankaranarayanan, Connor P. O’Hara, Umesh R. Desai · 2021 · ACS Medicinal Chemistry Letters
64. ACE2‐based decoy receptors for SARS coronavirus 2
    Wenyang Jing, Erik Procko · 2021 · Proteins Structure Function and Bioinformatics
65. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19
    Sreus A. G. Naidu, Taylor C. Wallace, Kelvin J.A. Davies, A. Satyanarayan Naidu · 2021 · Journal of Dietary Supplements
66. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
    Joyce van de Leemput, Zhe Han · 2021 · Molecular and Cellular Biology
67. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1
    Kiarash Saleki, Mohammad Banazadeh, Niloufar Sadat Miri, Abbas Azadmehr · 2021 · Reviews in the Neurosciences
68. COVID-19, Pre-Eclampsia, and Complement System
    Chiara Agostinis, Alessandro Mangogna, Andrea Balduit, Azin Aghamajidi, Giuseppe Ricci, Uday Kishore, Roberta Bulla · 2021 · Frontiers in Immunology
69. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
    Hataf Khan, Helena Winstone, Jose M. Jiménez-Guardeño, Carl Graham, Katie J. Doores, Caroline Goujon, David A. Matthews, Andrew D. Davidson, Suzannah J. Rihn, Massimo Palmarini et al. · 2021 · PLoS Pathogens
70. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
    Areez Shafqat, Shameel Shafqat, Sulaiman Alsalameh, Junaid Kashir, Khaled Manae AlKattan, Ahmed Yaqinuddin · 2022 · Frontiers in Immunology
71. Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection
    Masha G. Savelieff, Eva L. Feldman, Amro Maher Stino · 2022 · Neurobiology of Disease
72. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control
    Sreus A. G. Naidu, Roger Clemens, A. Satyanarayan Naidu · 2022 · Journal of Dietary Supplements
73. Coagulation Disorders in Sepsis and COVID-19—Two Sides of the Same Coin? A Review of Inflammation–Coagulation Crosstalk in Bacterial Sepsis and COVID-19
    Georgeana Tuculeanu, Ecaterina Constanța Barbu, Mihai Lazăr, Cristina Emilia Chițu, Emanuel Moisă, Silvius Ioan Negoita, Daniela Adriana Ion · 2023 · Journal of Clinical Medicine
74. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?
    Fialho, Maria Fernanda Pessano, Brum, Evelyne Silva, Oliveira, Sara Marchesan · 2023 · Inflammopharmacology
75. Is post-COVID syndrome an autoimmune disease?
    J. Anaya, María Herrán, Santiago Beltrán, M. Rojas · 2022 · Expert Review of Clinical Immunology
76. Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis
    Zheng‐Zhou Lu, Cong Sun, Xiaolin Zhang, Yingying Peng, Yan Wang, Yan Zeng, Nannan Zhu, Yan Yuan, Mu‐Sheng Zeng · 2023 · Science Advances
77. ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
    Melanie Engler, Dan Albers, Pascal von Maltitz, Rüdiger M. Groß, Jan Münch, Ion Cristian Cirstea · 2023 · Life Science Alliance
78. RGD‐binding integrins and TGF‐β in SARS‐CoV‐2 infections – novel targets to treat COVID‐19 patients?
    Ingrid Carvacho, Matthias Piesche · 2021 · Clinical & Translational Immunology
79. Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2
    Kapil Gupta, Christine Toelzer, Maia Kavanagh Williamson, Deborah K. Shoemark, A. Sofia F. Oliveira, David A. Matthews, Abdulaziz Almuqrin, Oskar Staufer, Sathish K.N. Yadav, Ufuk Borucu et al. · 2022 · Nature Communications
80. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
    Hamid Tanzadehpanah, Elham Lotfian, Amir Avan, Sahar Saki, Sima Nobari, Roghaye Mahmoodian, Mohsen Sheykhhasan, Mohamad Hosein Shafiee Froutagh, Farzaneh Ghotbani, Raoufeh Jamshidi et al. · 2023 · Biomedicine & Pharmacotherapy
81. Dual spatially resolved transcriptomics for human host–pathogen colocalization studies in FFPE tissue sections
    Hailey Sounart, Enikő Lázár, Yuvarani Masarapu, Jian Wu, Tibor Várkonyi, Tibor Glasz, András Kiss, Erik Borgström, Andrew Martin Hill, Sefanit Rezene et al. · 2023 · Genome biology
82. Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression
    Mariano Carossino, Paige Montanaro, Aoife Kateri O’Connell, Devin Kenney, Hans P. Gertje, Kyle A. Grosz, Maria Ericsson, Bertrand R. Huber, Susanna A. Kurnick, Saravanan Subramaniam et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
83. SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms
    Jiaqi Li, Huimin Jia, Miaomiao Tian, Nijin Wu, Xia Yang, Jianni Qi, Wanhua Ren, Feifei Li, Hongjun Bian · 2022 · Frontiers in Cellular and Infection Microbiology
84. Recent advances in the tumor‐penetrating peptide internalizing RGD for cancer treatment and diagnosis
    Jing Qian, Sheng Zhou, Peng Lin, Jin Lei, Shiqi Zheng, Wenmang Xu, Yuanyuan Wang, Ziran Gao, Ju-Lun Yang · 2023 · Drug Development Research
85. Neuropilin-1 is essential for vascular endothelial growth factor A–mediated increase of sensory neuron activity and development of pain-like behaviors
    Kimberly Gómez, Paz Duran, Raquel Tonello, Heather N. Allen, Lisa Boinon, Aida Calderón‐Rivera, Santiago Loya‐López, Tyler S. Nelson, Dongzhi Ran, Aubin Moutal et al. · 2023 · Pain
86. Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
    Camille R. Simoneau, Mélanie Ott · 2020 · Cell stem cell
87. Can drug repurposing strategies be the solution to the COVID-19 crisis?
    C. Bellera, M. Llanos, M. Gantner, Santiago Rodríguez, Luciana Gavernet, M. Comini, A. Talevi · 2020 · Expert Opinion on Drug Discovery
88. Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
    Nihar Ranjan Jena · 2021 · Chemical Physics Impact
89. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
    Adonis Sfera, C. Osorio, Carlos M. Zapata Martín del Campo, Shaniah Pereida, S. Maurer, J. C. Maldonado, Z. Kozlakidis · 2021 · Frontiers in Cellular Neuroscience
90. Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies
    Huyen Tran Ho, Stefan Peischard, Nathalie Strutz‐Seebohm, Karin Klingel, Guiscard Seebohm · 2021 · Viruses
91. COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2
    Dabing Li, Xiaoyan Liu, Lianmei Zhang, Jiayue He, Xianmao Chen, Shuguang Liu, Jiewen Fu, Shangyi Fu, Hanchun Chen, Junjiang Fu et al. · 2021 · International Journal of Biological Sciences
92. Synthesis, Structural Characterizations, and Quantum Chemical Investigations on 1-(3-Methoxy-phenyl)-3-naphthalen-1-yl-propenone
    Prakashgouda G. Patil, Raveendra M. Melavanki, Shivaraj B. Radder, Raviraj A. Kusanur, Chidanandayya S. Hiremath, Ninganagouda R. Patil, Sudhir M. Hiremath · 2021 · ACS Omega
93. Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
    Ravi Kant, Lauri Kareinen, Teemu Smura, Tobias L. Freitag, Sawan Kumar Jha, Kari K. Alitalo, Seppo Meri, Tarja A. Sironen, Kalle Saksela, Tomas M. Strandin et al. · 2021 · Viruses
94. Innate Immune Response in SARS-CoV-2 Infection
    Giovanna Schiuma, Silvia Beltrami, Daria Bortolotti, Sabrina Rizzo, Roberta Rizzo · 2022 · Microorganisms
95. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19
    Frits A.J. Muskiet, Pedro Carrera‐Bastos, Leo Pruimboom, Alejandro Lucía, David Furman · 2022 · Nutrients
96. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases
    Robyn S. Klein · 2022 · Current Opinion in Neurology
97. Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19
    Ikram Omar Osman, Clémence Garrec, Gabriel Augusto Pires de Souza, Ana Zarubica, Djamal Brahim Belhaouari, Jean‐Pierre Baudoin, Hubert Lépidi, Jean‐Louis Mège, Bernard MALISSEN, Bernard La Scola et al. · 2022 · Frontiers in Cellular and Infection Microbiology
98. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
    Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, E. Binshtein, Rita E. Chen, J. Case, Kevin J. Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette et al. · 2022 · bioRxiv
99. Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
    Renée Marije van der Sluis, Christian Kanstrup Holm, Martin R. Jakobsen · 2022 · Cell Reports
100. Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2
     Kexin Yan, Troy D. Dumenil, Bing Tang, Thuy T. Le, Cameron Bishop, Andreas Suhrbier, Daniel J. Rawle · 2022 · Virus Evolution